Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy.
Francesco Saverio MenniniAndrea MarcellusiSimone GazzilloClaudia NardonePaolo SciattellaRaffaele MiglioriniMarco Trabucco AurilioMario AmoreRoberto BrugnoliPublished in: Clinical drug investigation (2021)
Our study estimates an economic burden of schizophrenia of €1250 million per year in direct costs, of which 20% is related to hospitalizations and pharmaceutical expenditure. With regard to social security benefits, an average annual expenditure of €160.1 million was calculated (average cost per patient = €10,675).